Victory Capital Management
SANA icon

Victory Capital Management’s Sana Biotechnology SANA Stock Holding History

Victory Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.1K Buy
20,085
+1,063
+6% +$3.42K ﹤0.01% 2365
2026
Q1 		$54.8K Sell
19,022
-76
-0.4% -$299 ﹤0.01% 2308
2025
Q4 		$77.7K Buy
19,098
+2,463
+15% +$11K ﹤0.01% 2294
2025
Q3 		$59.1K Buy
16,635
+1,677
+11% +$6.06K ﹤0.01% 2327
2025
Q2 		$40.8K Sell
14,958
-24
-0.2% -$50 ﹤0.01% 2396
2025
Q1 		$25.2K Sell
14,982
-162
-1% -$453 ﹤0.01% 2415
2024
Q4 		$24.7K Sell
15,144
-222
-1% -$662 ﹤0.01% 2434
2024
Q3 		$63.9K Sell
15,366
-199
-1% -$1.04K ﹤0.01% 2371
2024
Q2 		$85K Buy
15,565
+55
+0.4% +$438 ﹤0.01% 2314
2024
Q1 		$155K Buy
15,510
+2,170
+16% +$16.3K ﹤0.01% 2253
2023
Q4 		$54.4K Buy
+13,340
New +$49.1K ﹤0.01% 2428
2022
Q3 		– Sell
-12,524
Closed -$81K – 2764
2022
Q2 		$81K Sell
12,524
-29
-0.2% -$185 ﹤0.01% 2486
2022
Q1 		$95K Sell
12,553
-358
-3% -$2.9K ﹤0.01% 2525
2021
Q4 		$200K Sell
12,911
-335
-3% -$6.46K ﹤0.01% 2487
2021
Q3 		$298K Buy
13,246
+1,122
+9% +$23.6K ﹤0.01% 2386
2021
Q2 		$238K Buy
+12,124
New +$275K ﹤0.01% 2493

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Victory Capital Management's SANA Position: Q2 2026 in Review

Victory Capital Management increased its Sana Biotechnology (SANA) stake by 5.6% in Q2 2026, buying an estimated $3.42K and bringing the position to 20,085 shares worth $70.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

Victory Capital Management first reported a position in SANA in Q2 2021 and has held it in 16 quarters since. The position peaked at $298K in Q3 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Victory Capital Management held 20,085 shares of Sana Biotechnology worth $70.1K as of Q2 2026.
  • Victory Capital Management bought 1,063 Sana Biotechnology shares in Q2 2026, an estimated $3.42K.
  • Sana Biotechnology made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2365 holding.
  • Victory Capital Management first reported a position in Sana Biotechnology in Q2 2021 and has held it in 16 quarters since.
  • Victory Capital Management's Sana Biotechnology position peaked at $298K in Q3 2021.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.